Interrater reliability of the Psychiatric Research Interview for Substance and Mental Disorders in an HIV-infected cohort: Experience of the National NeuroAIDS Tissue Consortium

Susan Morgello, C. E. Holzer, E. Ryan, C. Young, M. Naseer, S. A. Castellon, A. B. Frol, J. Hampton Atkinson, B. B. Gelman, I. Grant, E. J. Singer

Research output: Contribution to journalArticlepeer-review

35 Scopus citations

Abstract

The interrater reliability of the Psychiatric Research Interview for Substance and Mental Disorders (PRISM) was assessed in a multicentre study. Four sites of the National NeuroAIDS Tissue Consortium performed blinded reratings of audiotaped PRISM interviews of 63 HIV-infected patients. Diagnostic modules for substance-use disorders and major depression were evaluated. Seventy-six per cent of the patient sample displayed one or more substance-use disorder diagnoses and 54% had major depression. Kappa coefficients for lifetime histories of substance abuse or dependence (cocaine, opiates, alcohol, cannabis, sedative, stimulant, hallucinogen) and major depression ranged from 0.66 to 1.00. Overall the PRISM was reliable in assessing both past and current disorders except for current cannabis disorders when patients had concomitant cannabinoid prescriptions for medical therapy. The reliability of substance-induced depression was poor to fair although there was a low prevalence of this diagnosis in our group. We conclude that the PRISM yields reliable diagnoses in a multicentre study of substance-experienced, HIV-infected individuals.

Original languageEnglish (US)
Pages (from-to)131-138
Number of pages8
JournalInternational Journal of Methods in Psychiatric Research
Volume15
Issue number3
DOIs
StatePublished - 2006

Keywords

  • HIV
  • Interrater reliability
  • PRISM

ASJC Scopus subject areas

  • Psychiatry and Mental health

Fingerprint

Dive into the research topics of 'Interrater reliability of the Psychiatric Research Interview for Substance and Mental Disorders in an HIV-infected cohort: Experience of the National NeuroAIDS Tissue Consortium'. Together they form a unique fingerprint.

Cite this